Slocum, Gordon & Co’s Abbott ABT Stock Holding History

Slocum, Gordon & Co’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$376K	Hold	3,807	–	–	0.26%	48
2026 Q2	$345K	Buy	3,807 +7	+0.2%	+$639	0.23%	49
2026 Q1	$390K	Sell	3,800 -450	-11%	-$50.8K	0.27%	45
2025 Q4	$532K	Hold	4,250	–	–	0.39%	45
2025 Q3	$569K	Hold	4,250	–	–	0.45%	41
2025 Q2	$578K	Hold	4,250	–	–	0.47%	36
2025 Q1	$564K	Hold	4,250	–	–	0.42%	36
2024 Q4	$481K	Hold	4,250	–	–	0.4%	39
2024 Q3	$485K	Hold	4,250	–	–	0.19%	41
2024 Q2	$442K	Hold	4,250	–	–	0.33%	39
2024 Q1	$483K	Sell	4,250 -450	-10%	-$51.6K	0.36%	36
2023 Q4	$517K	Buy	+4,700	New	+$470K	0.45%	34
2023 Q3	–	Sell	-4,700	Closed	-$512K	–	147
2023 Q2	$512K	Hold	4,700	–	–	0.37%	34
2023 Q1	$476K	Sell	4,700 -1	-0%	-$106	0.39%	34
2022 Q4	$516K	Buy	+4,701	New	+$487K	0.33%	35

Other funds holding ABT

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $142B AUM 43.93% 1-Year Est. Return

Slocum, Gordon & Co's ABT Position: Q3 2026 in Review

Slocum, Gordon & Co held its Abbott (ABT) position steady in Q3 2026 at 3,807 shares worth $376K. The position accounts for 0.26% of the portfolio, ranked #48.

Slocum, Gordon & Co first reported a position in ABT in Q4 2022 and has held it in 15 quarters since. The position peaked at $578K in Q2 2025. 2,464 funds tracked by Wall St. Rank hold ABT as of Q3 2026.

Slocum, Gordon & Co held 3,807 shares of Abbott worth $376K as of Q3 2026.
Slocum, Gordon & Co left its Abbott share count unchanged in Q3 2026.
Abbott made up 0.26% of Slocum, Gordon & Co's portfolio in Q3 2026, its #48 holding.
Slocum, Gordon & Co first reported a position in Abbott in Q4 2022 and has held it in 15 quarters since.
Slocum, Gordon & Co's Abbott position peaked at $578K in Q2 2025.
2,464 funds tracked by Wall St. Rank held Abbott as of Q3 2026.

Based on Slocum, Gordon & Co's 13F filing for Q3 2026, filed 19 Oct 2026.